- Home
- Equipment
- north korea
- cardiac dysfunction
Refine by
Cardiac Dysfunction Equipment & Supplies In North Korea
7 equipment items found
Manufactured by:Magenta Medical Ltd. based inKadima, ISRAEL
The kidneys are the primary organs responsible for maintaining the body’s water and salt balance. As encapsulated organs, they are particularly vulnerable to congestion: cardiac dysfunction and fluid buildup/redistribution leads to increased central venous pressure, increased renal venous pressures and, ultimately, increased renal interstitial pressures. ...
Manufactured by:Jinshan Science & Technology (Group) Co., Ltd based inChonqing, CHINA
Conventional gastroscopy remains the widely accepted “gold standard” method for detecting and treating gastric pathology. However, patients with relative contraindications, such as severe cardiac or respiratory dysfunction, may not tolerate the stress of conventional examination. Patient’s discomfort and the need for sedation also limit ...
Manufactured by:Triple Hair Inc. based inDieppe, NEW BRUNSWICK (CANADA)
Vitamin/mineral supplement. Helps in the maintenance of good health. Contributes to the maintenance of healthy hair. This product helps to prevent hair loss caused by vitamin deficiency and to achieve healthier-looking ...
Manufactured by:Triple Hair Inc. based inDieppe, NEW BRUNSWICK (CANADA)
Vitamin/mineral supplement. Helps in the maintenance of good health. Contributes to the maintenance of healthy ...
Manufactured by:Triple Hair Inc. based inDieppe, NEW BRUNSWICK (CANADA)
Use RIZN Hair Density Spray and RIZN Hair Complex daily to maximize your hair’s regrowth ...
Manufactured by:Triple Hair Inc. based inDieppe, NEW BRUNSWICK (CANADA)
A strengthening, thickening and densifying hair care spray formulated to nourish the scalp and hair roots for thicker and fuller hair. This product is for continuous daily use. Allow 3-4 months of continuous usage for initial results to ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%). The effects diminish ...
